M. Svensson

发表

Change in the Amount of Body Fat and IL-6 Levels is Related to Altered Insulin Sensitivity in Type 1 Diabetes Patients with or without Diabetic Nephropathy

J. Eriksson, M. Svensson, M. Svensson, 2011, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy

J. Eriksson, M. Svensson, Z-W Yu, 2002, European journal of clinical investigation.

mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes

Maria J. Pereira, J. Eriksson, M. Aureliano, 2012, Molecular and Cellular Endocrinology.

Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.

J. Eriksson, G. Olivecrona, E. Makoveichuk, 2012, Metabolism: clinical and experimental.

Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle.

J. Eriksson, J. Jensen, T. Ruge, 2011, Metabolism: clinical and experimental.

Cumulative Risk, Age at Onset, and Sex-Specific Differences for Developing End-Stage Renal Disease in Young Patients With Type 1 Diabetes

L. Nyström, G. Dahlquist, H. Arnqvist, 2010, Diabetes.

Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study.

L. Nyström, G. Dahlquist, M. Svensson, 2006, Diabetes care.

Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden.

G. Dahlquist, J. Eriksson, M. Svensson, 2004, Diabetes care.

A case report of improved metabolic control after conversion from everolimus to cyclosporin A: role of adipose tissue mechanisms?

J. Eriksson, M. Svensson, M. J. Pereira, 2014, Transplantation proceedings.

Pharmacokinetic‐Pharmacodynamic Assessment of the Interrelationships Between Tesaglitazar Exposure and Renal Function in Patients With Type 2 Diabetes Mellitus

M. Karlsson, B. Hamrén, M. Svensson, 2012, Journal of clinical pharmacology.

Regional variation in use of exogenous and endogenous glomerular filtration rate (GFR) markers in Sweden

A. Larsson, C. Elinder, L. Marké, 2012, Upsala journal of medical sciences.

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia

O. Samuelsson, P. Attman, I. Gause-Nilsson, 2013, PPAR research.

How to diagnose and classify diabetes in primary health care: Lessons learned from the Diabetes Register in Northern Sweden (DiabNorth)

L. Weinehall, L. Nyström, S. Söderberg, 2012, Scandinavian journal of primary health care.

The risk for diabetic nephropathy is low in young adults in a 17‐year follow‐up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors

L. Nyström, M. Landin-Olsson, S. Gudbjörnsdottir, 2015, Diabetes/metabolism research and reviews.

Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study

M. Leósdóttir, A. Norhammar, G. Villa, 2022, Upsala journal of medical sciences.

Real‐World Effectiveness of Anti‐Resorptive Treatment in Patients With Incident Fragility Fractures—The STORM Cohort—A Swedish Retrospective Observational Study

T. Cars, B. Freyschuss, A. Kindmark, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up

J. Eriksson, K. Boman, M. Svensson, 2016, Diabetes & vascular disease research.

Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.

J. Eriksson, K. Boman, M. Svensson, 2009, Thrombosis research.

Factors in Serum from Type 2 Diabetes Patients Can Cause Cellular Insulin Resistance

F. Renström, J. Burén, J. Eriksson, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Assessment of beta‐cell function in young patients with type 2 diabetes: arginine‐stimulated insulin secretion may reflect beta‐cell reserve

L. Nyström, M. Landin-Olsson, S. Gudbjörnsdottir, 2014, Journal of internal medicine.

Cardiovascular disease in patients with renal disease: the role of statins

F. Zannad, R. Schmieder, A. Jardine, 2009, Current medical research and opinion.

Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes.

F. Renström, J. Burén, J. Eriksson, 2007, Metabolism: clinical and experimental.

Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects.

J. Burén, J. Eriksson, T. Olivecrona, 2003, Atherosclerosis.

The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue

J. Eriksson, E. Carvalho, M. Aureliano, 2013, Molecular and Cellular Endocrinology.

A Model for Glucose, Insulin, and Beta‐Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes

M. Karlsson, J. Ribbing, B. Hamrén, 2010, Journal of clinical pharmacology.

Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents.

J. Eriksson, E. Carvalho, M. Aureliano, 2014, The Journal of clinical endocrinology and metabolism.

Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.

L. Nyström, G. Sundkvist, J. Eriksson, 2007, Journal of diabetes and its complications.

Treatment target re-classification of subjects comparing estimation of low-density lipoprotein cholesterol by the Friedewald equation and direct measurement of LDL-cholesterol

E. Hagström, A. Larsson, L. Nilsson, 2018, Upsala journal of medical sciences.

Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

E. Hagström, A. Larsson, P. Ridefelt, 2019, Scandinavian journal of clinical and laboratory investigation.

Tissue‐specific regulation of lipoprotein lipase in humans: effects of fasting

J. Eriksson, G. Olivecrona, Jenny Casey Eriksson, 2005, European journal of clinical investigation.

The SNARE Protein SNAP23 and the SNARE-Interacting Protein Munc18c in Human Skeletal Muscle Are Implicated in Insulin Resistance/Type 2 Diabetes

J. Borén, C. Ling, E. Larsson, 2010, Diabetes.

Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’

F. Renström, J. Eriksson, T. Ruge, 2007, Diabetologia.

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

K. Blennow, H. Vanderstichele, E. Vanmechelen, 2007, Journal of Alzheimer's disease : JAD.

CDKN2C expression in adipose tissue is reduced in type 2 diabetes and central obesity: impact on adipocyte differentiation and lipid storage?

J. Kullberg, S. Skrtic, J. Eriksson, 2021, Translational research : the journal of laboratory and clinical medicine.

Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register

B. Eliasson, A. Svensson, M. Pirouzifard, 2015, Diabetologia.

Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes

C. Ling, P. Poulsen, A. Vaag, 2014, Diabetes.

Differentiation of Human Induced Pluripotent Stem Cells into Brown and White Adipocytes: Role of Pax3

C. Dani, P. Villageois, Austin G Smith, 2014, Stem cells.

Statin Dose Titration Patterns and Subsequent Major Cardiovascular Events in very High-Risk Patients - Estimates from Swedish Population-based Registry Data.

B. Eliasson, M. Lindh, M. Svensson, 2020, European heart journal. Quality of care & clinical outcomes.

Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data

M. Eriksson, K. Fox, M. Lindh, 2019, European heart journal. Quality of care & clinical outcomes.

Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study

E. Hagström, G. Villa, M. Svensson, 2021, Advances in Therapy.

Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients

B. Albinsson, O. Winqvist, J. Melin, 2021, BMC Immunology.

End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden

J. Sommar, G. Hallmans, I. Bergdahl, 2013, Environmental Health.

0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(5):2078–2084 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-031907 Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels

Bo Ahrén, P. Jansson, M. Landin-Olsson, 2022 .

Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes

G. Hallmans, O. Rolandsson, L. Mincheva-Nilsson, 2009, Autoimmunity.

Cardiovascular disease in patients with renal disease: the role of statins

F. Zannad, R. Schmieder, A. Jardine, 2009 .

Insulin resistance in diabetic nephropathy — cause or consequence?

J. Eriksson, M. Svensson, Jan W. Eriksson, 2006, Diabetes/metabolism research and reviews.

Metabolic aspects on diabetic nephropathy

M. Svensson, 2003 .

Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?

O. Hammarsten, C. Lindberg, M. Svensson, 2021, Journal of Nephrology.

Reduced renal function in patients with Myotonic Dystrophy type 1 and the association to CTG expansion and other potential risk factors for chronic kidney disease

C. Lindberg, M. Svensson, A. Aldenbratt, 2017, Neuromuscular Disorders.

Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.

F. Renstrom, J. Eriksson, T. Ruge, 2009, Metabolism: clinical and experimental.

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients

G. Gambaro, C. Emde, F. Dekker, 2019, Journal of the American Heart Association.

Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

L. Nyström, G. Sundkvist, J. Eriksson, 2003, Diabetes care.

The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

L. Nyström, G. Sundkvist, J. Eriksson, 2003, Diabetes care.

Characterization of brown adipose tissue in the human perirenal depot

C. Dani, P. Svensson, A. Hafner, 2014, Obesity.

A Functional Polymorphism in the Manganese Superoxide Dismutase Gene and Diabetic Nephropathy

C. Forsblom, P. Groop, S. Marklund, 2007, Diabetes.

Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance

S. Skrtic, J. Eriksson, Petros Katsogiannos, 2016, Endocrine.

Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy

C. Forsblom, P. Groop, G. Dahlquist, 2006, Annals of medicine.

The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk.

I. Kockum, G. Dahlquist, J. Eriksson, 2008, Journal of diabetes and its complications.

End-stage renal disease and low level exposure to lead , cadmium and mercury ; a population-based , prospective nested case-referent study in

J. Sommar, G. Hallmans, I. Bergdahl, 2013 .

Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).

S. Gudbjörnsdottir, J. Cederholm, B. Eliasson, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Abdominal Aortic Calcifications Predict Survival in Peritoneal Dialysis Patients

J. Uhlinova, M. Ots-Rosenberg, S. Mäkelä, 2018, Peritoneal Dialysis International.

Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register

S. Gudbjörnsdottir, B. Eliasson, A. Svensson, 2017, Diabetes & vascular disease research.

Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17years after the diagnosis of diabetes - A retrospective observational nation-wide cohort study.

L. Nyström, M. Landin-Olsson, S. Gudbjörnsdottir, 2017, Diabetes research and clinical practice.

Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study

L. Lönn, L. Lind, P. Jansson, 2008, Hypertension.

Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study

J. Dereke, M. Hillman, M. Landin-Olsson, 2017, Diabetology & Metabolic Syndrome.

Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity?

J. Kullberg, U. Wiklund, L. Johansson, 2016, Cardiovascular Diabetology.

FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance.

T. Fall, P. Svensson, J. Eriksson, 2014, Metabolism: clinical and experimental.

Prevalence of Chronic Kidney Disease in Unselected Swedish Patients with Type 2 Diabetes and its Association with Cardiovascular Disease

C. Ostgren, L. Weiss, M. Svensson, 2014 .

Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.

S. Gudbjörnsdottir, B. Eliasson, A. Svensson, 2013, Journal of diabetes and its complications.

Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register

S. Gudbjörnsdottir, J. Cederholm, B. Eliasson, 2013, Diabetes & vascular disease research.

Body composition in patients with primary neuromuscular disease assessed by dual energy X-ray absorptiometry (DXA) and three different bioimpedance devices.

L. Ellegård, C Lindberg, L Ellegård, 2019, Clinical nutrition ESPEN.

Evaluation of simple non‐invasive techniques for assessment of lower extremity arterial disease

J. Eriksson, M. Svensson, D. Sahli, 2005, Clinical physiology and functional imaging.

Differences between men and women in the regulation of adipose 11β‐HSD1 and in its association with adiposity and insulin resistance

F. Renström, J. Eriksson, A. Rees, 2013, Diabetes, obesity & metabolism.

Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve

O. Hammarsten, M. Svensson, C. Guron, 2020, ESC heart failure.

Assessment of Toe Blood Pressure Is an Effective Screening Method to Identify Diabetes Patients with Lower Extremity Arterial Disease

B. Eliasson, J. Eriksson, G. Blohmé, 2004, Angiology.

Evaluation of reference genes for gene expression studies in human brown adipose tissue

P. Svensson, J. Eriksson, J. Andersson-Assarsson, 2015, Adipocyte.

The dual peroxisome proliferator–activated receptor α/γ agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin

S. Tonstad, K. Retterstøl, L. Ose, 2007 .

No Direct Link between Albumin Excretion Rate and Insulin Resistance - A Study in Type 1 Diabetes Patients with Mild Nephropathy

J. Eriksson, M. Svensson, 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes

J. Sundström, B. Eliasson, J. Eriksson, 2023, Diabetes & vascular disease research.